Monday, 22 July 2013

23 July, 2013

Did WHO promote vaccines in India not in use in other countries?

A leading Indian journal of medical ethics has charged the World Health Organisation (WHO) of promoting a vaccine in this country that has been discontinued elsewhere, following adverse reactions and deaths in children. In a hard-hitting editorial piece, the Indian Journal of Medical Ethics (IJME) has accused WHO of promoting Pentavalent vaccine “by stating falsely that no adverse event following immunisation (AEFI) has ever been reported with the vaccine”. The journal claims this is contrary to facts. The editorial, by Jacob Puliyel, head of paediatrics at St. Stephen’s Hospital in Delhi, is based on his detailed investigation into the deaths of children in Bhutan, Sri Lanka, India and Vietnam following the administration of Pentavalent vaccine.
This vaccine combines the Diphtheria, Pertusis, Tetanus or DPT vaccine — long used in national immunisation programmes — with Hepatitis-B and H influenza-b or Hib vaccine. This combination vaccine is not licensed for use by the US Food and Drug Administration, nor is it used in other developed countries, the editorial claims. The IJME editorial says that on May 4, 2013, the Ministry of Health of Vietnam suspended Quinvaxem – the Pentavalent combination used in that country — after 12 deaths and nine other non-fatal serious adverse events. The WHO, which investigated the incident, said the deaths were not vaccine-related and asserted that “Quinvaxem was prequalified by WHO and no fatal adverse event following immunisation has ever been associated with this vaccine”.
The journal goes on to say that serious adverse reactions and deaths have now been reported with Pentavalent vaccine produced by other manufacturers in a number of countries. Bhutan, Sri Lanka and Pakistan have even stopped using the vaccine. In India, according to IJME, 21 children have so far died in a limited experiment with the vaccine introduced in 2011 in the immunisation programme of Tamil Nadu and Kerala. India had announced plans to roll out the vaccine in other states after monitoring its impact in these two states.


23.07.2013



Health Ministry says iron and folic acid tablets have side effects!

The central government on Monday clarified that vomiting, abdominal pain and general discomfort were sometimes reported as side effects of iron and folic acid tablets, and should not be a cause for worry. The iron and folic acid supplementation programme has been underway in some states from last year. It was introduced in the national capital last week.
Around 200 children in Delhi, it was reported, had severe stomach ache and vomiting. Some children were admitted to hospital. ‘The IFA (iron and folic acid) tablets are very safe, but there could be a miniscule number of cases where there is some discomfort,’ Anuradha Gupta, additional secretary and mission director, National Rural Health Mission (NRHM), said at a press conference. (Read: Why the programme is a bad idea?)
Gupta said in India, anaemia is a serious problem affecting nearly 90 percent of women. ‘The IFA supplementation programme is a very serious programme and if it is derailed for some minor issues, it would be a great loss,’ she said.
Gupta said out of the 18 lakh children administered the IFA tablets in Delhi, only 200 reported sick. According to studies conducted in India, 5-15 percent of people given the IFA supplementation can report side effects. ‘In our programme, less than 0.1 percent of people have reported side effects,’ she said. Sidharth Ramji, professor of paediatrics at the Maulana Azad Medical College, Delhi, who was part of the fact-finding team for the north Delhi area where 200 children fell sick, however, said that no reason had been found for the children to have the symptoms.
‘In all the schools and anganwadi centres, strict guidelines had been followed while administering the tablets,’ he said, adding that some children had problems from before the administration of the supplements, which were exacerbated afterwards. He also clarified that the tablets were of fresh stock, and had been procured only in June, with an expiry date of 2015.
Apart from the incident in Delhi, children have also reportedly fallen sick in Maharashtra after taking the tablets. Gupta said that the protocol on side effects form a part of the guidelines given to teachers and anganwadi workers who administer the tablets.

23.07.2013







We may not all do great things, but we can all do small things with great love

Mother Teresa

No comments:

Post a Comment